ASR Vermogensbeheer’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13.3M Buy
328,233
+28,946
+10% +$1.29M 0.13% 145
2026
Q2
$14M Buy
299,287
+22,366
+8% +$1.03M 0.14% 145
2026
Q1
$13.6M Buy
276,921
+4,688
+2% +$218K 0.16% 132
2025
Q4
$11.9M Buy
272,233
+60,250
+28% +$2.75M 0.14% 142
2025
Q3
$9.5M Buy
211,983
+7,292
+4% +$320K 0.12% 162
2025
Q2
$8.89M Buy
204,691
+36,832
+22% +$1.64M 0.12% 169
2025
Q1
$7.73M Buy
+167,859
New +$7.02M 0.11% 173

Other funds holding EXC

ASR Vermogensbeheer's EXC Position: Q3 2026 in Review

ASR Vermogensbeheer increased its Exelon (EXC) stake by 9.7% in Q3 2026, buying an estimated $1.29M and bringing the position to 328,233 shares worth $13.3M. The position accounts for 0.13% of the portfolio, ranked #145.

ASR Vermogensbeheer first reported a position in EXC in Q1 2025 and has held it in 7 quarters since. The position peaked at $14M in Q2 2026. 299 funds tracked by Wall St. Rank hold EXC as of Q3 2026.

  • ASR Vermogensbeheer held 328,233 shares of Exelon worth $13.3M as of Q3 2026.
  • ASR Vermogensbeheer bought 28,946 Exelon shares in Q3 2026, an estimated $1.29M.
  • Exelon made up 0.13% of ASR Vermogensbeheer's portfolio in Q3 2026, its #145 holding.
  • ASR Vermogensbeheer first reported a position in Exelon in Q1 2025 and has held it in 7 quarters since.
  • ASR Vermogensbeheer's Exelon position peaked at $14M in Q2 2026.
  • 299 funds tracked by Wall St. Rank held Exelon as of Q3 2026.

Based on ASR Vermogensbeheer's 13F filing for Q3 2026, filed 16 Oct 2026.